Cerebral Vein Thrombosis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Cerebral Vein Thrombosis trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 20 trials

RecruitingPhase 3

NCT07430956

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is…

This study is researching 2 different experimental drugs called REGN7508 and REGN9933 (called "study drugs"). The study is focused on people who have atrial fib…

United States2,628 participantsStarted 2026-04-03

Treatment: REGN7508, REGN9933

RecruitingNot Applicable

NCT05628207

Evaluation of the SCALED (SCaling AcceptabLE cDs)

This project will adapt a currently deployed Clinical Decision Support (CDS) system to deliver a VTE prevention guideline for adult patients with traumatic brai…

United States15,000 participantsStarted 2023-05-16

Treatment: Observational, Observational-control

RecruitingPhase 4

NCT07521332

Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis

The APIXABAN-PK trial is a prospective, randomized, single-blind, placebo-controlled study designed to evaluate the efficacy and safety of apixaban in combinati…

Pakistan220 participantsStarted 2026-04-01

Treatment: Apixaban, Carvedilol

RecruitingNot Applicable

NCT06753786

Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage

The objective of this randomized clinical trial is to evaluate the safety and efficiency of different anticoagulation schemes with heparin for venous thromboemb…

Russia200 participantsStarted 2024-10-21

Treatment: Venous thromboembolism prophylaxis with unfractionated heparin or low molecular weight heparin starting within the first 2 days but not earlier than 12 hours after a hospital admission., Venous thromboembolism prophylaxis with unfractionated heparin or low molecular weight heparin starting on the 3rd day after a hospital admission.

RecruitingNot Applicable

NCT04992195

Impact of COVID-19 Vaccines on Cerebrovascular Health

Safe and effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines may reduce the transmission of and achieve population immunity against…

Hong Kong500 participantsStarted 2021-07-05

Treatment: Laboratory tests and Montreal Cognitive Assessment, Laboratory tests and Montreal Cognitive Assessment

RecruitingPhase 4

NCT07352358

Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis

A total of 72 patients meeting the diagnostic criteria for acute cerebral venous thrombosis were included in this study. A multi-center stratified randomization…

China72 participantsStarted 2026-01-30

Treatment: batroxobin, Anticoagulation Agents

All recent trials (100 shown)

Not Yet RecruitingNot Applicable

NCT07548346

MENA Regional Endovascular Intervention for Venous Cerebral Venous Sinus Thrombosis

REVIVE-CVST is a multicenter, prospective, randomized, open-label, blinded-endpoint (PROBE) trial evaluating whether early endovascular thrombectomy (EVT) combi…

Egypt, Jordan440 participantsStarted 2026-07

Treatment: Endovascular Thrombectomy, Anticoagulation Therapy

Active — Not RecruitingNot Applicable

NCT05491980

Florida Cerebrovascular Disease Biorepository and Genomics Center

The purpose of this study is to create a state-wide biorepository and resource center for cerebrovascular diseases in Florida, which will include collecting med…

United States72 participantsStarted 2022-08-02

Cerebral Vein Thrombosis

Trial phase breakdown

Trial status

Actively recruiting — 20 trials

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is…

Evaluation of the SCALED (SCaling AcceptabLE cDs)

Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis

Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage

Impact of COVID-19 Vaccines on Cerebrovascular Health

Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis

All recent trials (100 shown)

MENA Regional Endovascular Intervention for Venous Cerebral Venous Sinus Thrombosis

Florida Cerebrovascular Disease Biorepository and Genomics Center

Trial phase breakdown

Trial status

Actively recruiting — 20 trials

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is…

Evaluation of the SCALED (SCaling AcceptabLE cDs)

Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis

Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage

Impact of COVID-19 Vaccines on Cerebrovascular Health

Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis

All recent trials (100 shown)

MENA Regional Endovascular Intervention for Venous Cerebral Venous Sinus Thrombosis

Florida Cerebrovascular Disease Biorepository and Genomics Center

Weekly Monitoring Strategy of Capillary INR Versus Monthly Monitoring Strategy of Venous INR in Elderly Patients in a Nu…

COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Comp…

Intracranial Hypertension and Optic Nerve Sheath Diameter

Glymphatic Function and White Matter Integrity in Cerebral Venous Disorders

Steroid for Treatment of Acute/Subacute Severe Cerebral Venous Thrombosis.

DOAC in Unusual Site Venous Thrombosis

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation…

Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome

Thrombosis Outcomes in Pediatric Venous Thromboembolism

Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study

Philippine Neurological Association One Database - Stroke

The Dedicated Venous Sinus Thrombectomy Stent for Endovascular Treatment of Cerebral Venous Sinus Thrombosis.

Paroxysmal Nocturnal Hemoglobinuria in ESUS & ETUS

Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache

Outcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and Wales

LIFE - Lung Cancer, Immunotherapy, Frailty, Effect

Development and Validation of Automated Indicators on the Appropriateness of Oral Anticoagulant Prescriptions

Multicenter Registry Study Of Cerebral Venous Thrombosis In China (RETAIN-CH)